Chennai: Necessity is the mother of all inventions. The Covid-19 pandemic has unlocked India’s vast potential in the field of life sciences and biotechnology.
The pandemic has acted like a catalyst in nurturing an ecosystem of innovation within the country and expanding research and development. One of the products that has been an outcome of this is Scalene Hypercharge Corona Canon (Shycocan), a scientific invention device with the “ability to contain the spread of coronavirus”.
Shycocan was introduced to the public by Medwin Healthcare, a Kolkata based company that undertakes various projects related to healthcare and social engineering, through a virtual session.
Medwin claimed Shycocan was approved by the USFDA and EU Confirmite Europenne. Dr Rajah Vijay Kumar, Indian scientist and chairman and chief scientific officer, Organization de Scalene and Scalene Cybernetics Ltd., Bengaluru and the inventor of Shycocan, said, “it is proven to be 99.9 per cent effective in neutralising the spike-protein or S-protein that are present in coronavirus.”